Page last updated: 2024-11-05

thalidomide and Deficiency, Vitamin B

thalidomide has been researched along with Deficiency, Vitamin B in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FELISATI, D1
PARTSCH, CJ1
MAURER, H1

Other Studies

2 other studies available for thalidomide and Deficiency, Vitamin B

ArticleYear
TERATOGENIC ACTION OF THALIDOMIDE.
    Lancet (London, England), 1964, Mar-28, Volume: 1, Issue:7335

    Topics: Abnormalities, Drug-Induced; Female; Folic Acid; Glutamine; Niacinamide; Pregnancy; Pregnancy Compli

1964
[ON THE FORMAL GENESIS OF EAR ABNORMALITIES IN THALIDOMIDE EMBRYOPATHY].
    Archiv fur Ohren-, Nasen- und Kehlkopfheilkunde, 1963, Dec-09, Volume: 182

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Coenzymes; Ear; Fetal Diseases; Humans; Infant

1963